| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |